Pseudohypoaldosteronism Type 1 with a Novel Mutation in the NR3C2 Gene: A Case Report
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Pseudohypoaldosteronism type 1 (PHA1) is a rare salt-wasting disorder caused by resistance to mineralocorticoid action. PHA1 is of two types with different levels of disease severity and phenotype as follows: systemic type with an autosomal recessive inheritance (caused by mutations of the epithelial sodium channel) and renal type with an autosomal dominant inheritance (caused by mutations in the mineralocorticoid receptor). The clinical manifestations of PHA1 vary widely; however, PHA1 commonly involves hyponatremia, hyperkalemia, metabolic acidosis and elevated levels of renin and aldosterone. The earliest signs of both type of PAH1 also comprise insufficiency weight gain due to chronic dehydration and failure to thrive during infancy. Here, we report a case of renal PAH1 in a 28-day-old male infant harboring a novel heterozygous mutation in NR3C2 gene (c.1341_1345dupAAACC in exon 2), showing only failure to thrive without the characteristic of dehydration.
Abstract
Pseudohypoaldosteronism type 1 (PHA1) is a rare salt-wasting disorder caused by resistance to mineralocorticoid action. PHA1 is of two types with different levels of disease severity and phenotype as follows: systemic type with an autosomal recessive inheritance (caused by mutations of the epithelial sodium channel) and renal type with an autosomal dominant inheritance (caused by mutations in the mineralocorticoid receptor). The clinical manifestations of PHA1 vary widely; however, PHA1 commonly involves hyponatremia, hyperkalemia, metabolic acidosis and elevated levels of renin and aldosterone. The earliest signs of both type of PAH1 also comprise insufficiency weight gain due to chronic dehydration and failure to thrive during infancy. Here, we report a case of renal PAH1 in a 28-day-old male infant harboring a novel heterozygous mutation in NR3C2 gene (c.1341_1345dupAAACC in exon 2), showing only failure to thrive without the characteristic of dehydration.
참고문헌 (15)
- Bizzarri C, "Water Balance and 'Salt Wasting' in the First Year of Life : The Role of Aldosterone-Signaling Defects", Horm Res Paediatr, 86, pp.143~153 (2016)
- White PC, "Nelson textbook of pediatrics", pp.2711~2714 (2016), Elsevier Saunders
- 정해일, "Pseudohypoaldosteronism Type 1", Journal of Genetic Medicine, 10(2), pp.81~87 (2013), 대한의학유전학회
- Geller DS, "Mineralocorticoid resistance", Clin Endocrinol(Oxf), 62, pp.513~520 (2005)
- Riepe FG, "Pseudohypoaldosteronism", Endocr Dev, 24, pp.86~95 (2013)
- Amin N, "Pseudohypoaldosteronism type 1 : clinical features and management in infancy", Endocrinol Diabetes Metab Case Rep, 2013, pp.130010~ (2013)
- Orth DN, "Methods of hormone radioimmunoassay", pp.245~279 (1978), Academic Press
- Voilley N, "Cloning, chromosomal localization, and physical linkage of the beta and gamma subunits (SCNN1B and SCNN1G) of the human epithelial amiloride-sensitive sodium channel", Genomics, 28, pp.560~565 (1995)
- Chang SS, "Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1", Nat Genet, 12, pp.248~253 (1996)
- Geller DS, "Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type I", Nat Genet, 19, pp.279~281 (1998)
- 김수연, "SCNN1A 유전자 변이로 발생한 상염색체 열성 가성 저알도스테론증 1형 1례", Childhood Kidney Diseases, 17(2), pp.137~142 (2013), 대한소아신장학회
- Korkut S, "Clinical Course and Follow-Up of Type 1 Pseudohypoaldosteronism", Erciyes Med J, 40, pp.113~119 (2018)
- Se Eun Lee, "A case of pseudohypoaldosteronism type 1 with a mutation in the mineralocorticoid receptor gene", Clinical and Experimental Pediatrics, 54(2), pp.90~93 (2011), 대한소아청소년과학회
- Kang IN, "A case of pseudohypoaldosteronism", J Korean Pediatr Soc, 38, pp.1160~1163 (1995)
- Geller DS, "Autosomal dominant pseudohypoaldosteronism type 1: mechanisms, evidence for neonatal lethality, and phenotypic expression in adults", J Am Soc Nephrol, 17, pp.1429~1436 (2006)